Cardiovascular risk associated to menopause
XPS (Español (España))
PDF (Español (España))
JPG (Español (España))
صندلی اداری سرور مجازی ایران Decentralized Exchange

How to Cite

1.
Bolaños Chaves BD, Ortega Muñoz E. Cardiovascular risk associated to menopause. Rev.méd.sinerg. [Internet]. 2021Jan.1 [cited 2024Jul.22];6(1):e629. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/629

Abstract

Cardiovascular disease represents one of the main causes of mortality in postmenopausal women. After menopause, there are many factors that increase the real risk of cardiovascular disease, including smoking, high blood pressure, dyslipidemias, type two diabetes mellitus, age at menarche and menopause, and vasomotor symptoms, in addition, the traditional risk factors of the transition period, such as decreased glucose tolerance and endothelial dysfunction. Also, other factors are included, such as primary ovarian dysfunction and surgical menopause, which usually advance all the physiological processes of a natural menopause, resulting in a significant increase in cardiovascular risk.

https://doi.org/10.31434/rms.v6i1.629

Keywords

menopause. cardiovascular diseases. coronary disease. premature menopause. estrogen replacement therapy.
XPS (Español (España))
PDF (Español (España))
JPG (Español (España))

References

Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019; 4: e553–64. https://doi.org/10.1016/S2468-2667(19)30155-0

Muka T, Oliver-Williams C, Colpani V, Kunutsor S, Chowdhury S, et al. (2016) Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. PLOS ONE 11(6): e0157417. https://doi.org/10.1371/journal.pone.0157417

P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber (2016) Cardiovascular risk assessment in women – an update, Climacteric, 19:4, 329-336. https://doi.org/10.1080/13697137.2016.1198574

Arteaga Urzúa E. Menopausia y riesgo cardiovascular. Rev Med Chil. 2016 Nov;144(11):1375-1376. http://dx.doi.org/10.4067/S0034-98872016001100001

Bernhardt L, Lawson CA. Early menopause and risk of cardiovascular disease: an issue for young women. Lancet Public Health. 2019 Nov;4(11): e539-e540. https://doi.org/10.1016/ S2468-2667(19)30184-7

Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Michos ED. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women. J Am Coll Cardiol. 2018 Jun 5;71(22):2555-2566. https://doi.org/10.1016/j.jacc.2018.01.083

Fonseca, M.I.H., da Silva, I.T. & Ferreira, S.R.G. Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?. Diabetol Metab Syndr 9, 22 (2017). https://doi.org/10.1186/s13098-017-0221-5

de Kat, A.C., Dam, V., Onland-Moret, N.C. et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med 15, 2 (2017). https://doi.org/10.1186/s12916-016-0762-8

Honigberg MC, Zekavat SM, Aragam K, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019;322(24):2411–2421. https://doi.org/10.1001/jama.2019.19191

Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi RE. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017 Aug;20(4):306-312. http://dx.doi.org/10.1080/13697137.2017.1315089

Cagnacci A, Palma F, Romani C, Xholli A, Bellafronte M, Di Carlo C. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women?. Gynecological Endocrinology 2015; 31:5, 359-362. https://doi.org/10.3109/09513590.2014.998188

Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, Kavousi M. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas 81 (2015) 353-361. http://dx.doi.org/10.1016/j.maturitas.2015.04.016

Abbas SZ, Sangawan V, Das A, Pandey AK. Assessment of Cardiovascular Risk in Natural and Surgical Menopause. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):223-228. https://doi.org/10.4103/2230-8210.232384

Naftolin F, Friedenthal J, Nachtigall R and Nachtigall L. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Research 2019, 8(F1000 Faculty Rev):1576. https://doi.org/10.12688/f1000research.15548.1

Boardman HMP, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD002229. https://doi.org/10.1002/14651858.CD002229.pub4

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2021 Array

Downloads

Download data is not yet available.
فروشگاه اینترنتی صندلی اداری جوراب افزایش قد ژل افزایش قد صندلی اداری vpn for android خرید vpn